Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition
开发口服生物可利用的 CDK12/13 降解剂并通过抑制 AKT 通路诱导合成致死
期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2024.101752
Yu Chang, Xiaoju Wang, Jianzhang Yang, Jean Ching-Yi Tien, Rahul Mannan, Gabriel Cruz, Yuping Zhang, Josh N Vo, Brian Magnuson, Somnath Mahapatra, Hanbyul Cho, Saravana Mohan Dhanasekaran, Cynthia Wang, Zhen Wang, Licheng Zhou, Kaijie Zhou, Yang Zhou, Pujuan Zhang, Weixue Huang, Lanbo Xiao, Weihuang